Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-5.60	45.62	48.33
Graham Fair Price	5.15	23.66	22.51
PEG	100.00	3.01	0.00
Price/Book	-16.04	1.67	1.99
Price/Cash Flow	119.65	333.03	-151.62
Prices/Earnings	-21.03	25.51	32.30
Price/Sales	-8.17	17.56	19.13
Price/FCF	119.65	333.03	-151.62
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.15	0.35	0.33
Operating Margin	9.65	0.23	0.21
ROA	1.97	< 0.005	< 0.005
ROE	0.02	0.02	6.32
ROIC	< 0.005	0.01	14.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.13	0.06	123.37
Dividends QOQ	< 0.005	< 0.005	11.25
EBIT QOQ	0.37	0.02	-95.06
EPS QOQ	0.00	0.08	100.00
FCF QOQ	0.79	1.39	76.61
Revenue QOQ	0.16	-0.07	-55.52
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	24.88	33.36	34.05
Days Sales Outstanding (DSO)	101.28	85.15	-15.93
Inventory Turnover	3.62	2.70	-25.40
Debt/Capitalization	0.48	0.50	5.56
Quick Ratio	0.87	0.76	-13.01
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	38.20	38.95	1.97
Cash	3.23	3.34	3.31
Capex	-2.80	-1.71	38.80
Free Cash Flow	-0.50	0.20	-61.02
Revenue	3.98	3.71	-6.76
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.20	1.12	-7.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.19	16.29	14.81
Naive Interpretation	Member

06 - Financial Health · Bad

Rating